SSRI CHINA news

On March 31st, 2022, SSRI and M3 launched the updated version of PatientsMap China.

PatientsMap is a database product which uncovers the types of diseases that various specialists see, and the monthly patient volume for each disease. It also includes data for sales rep visitation rates of various pharmaceutical companies.
PatientsMap can be used as a tool for estimating nationwide patient numbers for various diseases across, not only different specialties, but also by hospital tiers and city tiers. It can help you in analyzing the potential of a new drug and also for targeting the appropriate specialties in terms of market research and/or for promotional purposes.

PatientsMap China 2022 data was collected from over 11,000 physicians, covering approximately 400 diseases/conditions. PatientsMap data collection is conducted via online in collaboration with M3.

Outline of PatientsMap 2022 China:
1. Product name: PatientsMap 2022 China
2. Objective: To understand the treatment condition of various specialties for 402 diseases/conditions
3. Methodology: Online survey
4. Survey region: Nationwide
5. Sample size: 11,106 physicians from various departments
6. Fieldwork schedule: 2021 December – 2022 March

Contents of PatientsMap:

• > Total number of patients that they see (per month)
• > Diseases/conditions that they see (402 disease types)
• > Number of patients they see per each disease/condition
• > Number of patients in which they prescribe medications for that disease/condition
• > Diseases in which they wish for new product development
• > Sales rep visitations in the past month (64 manufacturers)
• > Information provision via non-face-to-face methods (64 manufacturers)
• > Demographics
•      - Primary specialty
•      - Area of specialty/sub-specialties
•      - Province and city of the practice
•      - Hospital type and tier level
•      - Number of beds at the hospital
•      - Title
•      - Age range

For more information on PatientsMap, please contact; patientsmap@ssri.com

For more information on PatientsMap CN, please contact (Jane Zhang); zhangjun@ssrichina.com